Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446651 · ClinicalTrials.gov registry record · Early Phase 1
Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
NCT03446651 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 50 participants.
The verdict
NCT03446651, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effects of chloride supplementation on volume-overloaded acute heart failure patients concomitantly treated with IV diuretics.
Interventions
- OTHER Placebo
- DRUG Lysine Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2022-09-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03446651
The ClinicalTrials.gov registry entry for NCT03446651 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03446651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03446651 about?
NCT03446651 is a clinical study titled "Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure". The purpose of this study is to understand the effects of chloride supplementation on volume-overloaded acute heart failure patients concomitantly treated with IV diuretics.
What is the current status of trial NCT03446651?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2018-07-12. Estimated completion is 2022-09-07.
What interventions are being tested in trial NCT03446651?
The interventions under investigation include: Placebo (OTHER), Lysine Chloride (DRUG).
Who is sponsoring clinical trial NCT03446651?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.